Shanghai, Sep 6, 2019 - Frontage Holdings Corporation (“Frontage Holdings” or “Frontage,” stock code: 1521.HK), a Contract Research Organization (“CRO”) providing integrated, science-driven research, analytical and product development services in both the U.S. and China, announced today the opening of a new lab facility in Shanghai, China. 

News

Featured Frontage Holdings launched a new 42,000 sq.ft. lab in Shanghai, China
9.11.2019

Frontage Holdings launched a new 42,000 sq.ft. lab in Shanghai, China

Shanghai, Sep 6, 2019 - Frontage Holdings Corporation (“Frontage Holdings” or “Frontage,” stock code: 1521.HK), a Contract Research Organization (“CRO”) providing integrated, science-driven research, analytical and product development services in both the U.S. and China, announced today the opening of a new lab facility in Shanghai, China. 
Read Full Story
8.20.2019

Frontage Holdings Announces 2019 Interim Results

Frontage Holdings Corporation (“Frontage” , “Frontage Holdings” or “the Group”, stock code: 1521.HK), a Contract Research Organization (“CRO”) providing integrated, scientifically-driven research, analytical and development services with presence in both the United States and China, today announces its unaudited interim results for the six months ended June 30, 2019.
Read Full Story
News Frontage Clinical Services, Inc. Expands Facilities to Accommodate Tobacco and Nicotine-Related Studies
8.13.2019

Frontage Clinical Services, Inc. Expands Facilities to Accommodate Tobacco and Nicotine-Related Studies

Frontage Clinical Services, Inc. (“Frontage Clinical”), an associate of Frontage Laboratories, Inc. (“Frontage Labs”), is pleased to announce completion of renovations to Frontage Clinical’s center in Secaucus, New Jersey, to now accommodate clinical studies on tobacco and nicotine-containing products. This expansion highlights Frontage Clinical’s commitment to the investigation of the safety of new tobacco alternatives.
Read Full Story
News Frontage Receives 2019 CRO Leadership Awards
7.1.2019

Frontage Receives 2019 CRO Leadership Awards

Frontage Laboratories, Inc., a wholly owned subsidiary of Frontage Holdings Corporation (HK.1521), has once again been named as a CRO Leadership Awards recipient by Life Science Leader magazine.
Read Full Story
News Frontage Holdings Corporation Celebrates a Successful Initial Public Offering on the HKEx
6.3.2019

Frontage Holdings Corporation Celebrates a Successful Initial Public Offering on the HKEx

Frontage Holdings Corporation, the parent company of Frontage Laboratories, Inc., a fast-growing contract research organization, specializing in R&D product development services, with operations in both the United States and China, announced on May 30th that the Company's Shares have initiated trading on the Main Board of The Stock Exchange of Hong Kong
Read Full Story
News Frontage Appoints Sridhar Krishnan as Senior Vice President of Global Operations!
5.9.2019

Frontage Appoints Sridhar Krishnan as Senior Vice President of Global Operations!

As Senior Vice President of Global Operations, Sridhar will be responsible for integrating business units and provide operational excellence leadership across the Frontage organization.
Read Full Story
News Frontage Appoints Joe (Yifeng) Gao as Chief Financial Officer (CFO)
1.10.2019

Frontage Appoints Joe (Yifeng) Gao as Chief Financial Officer (CFO)

As Chief Financial Officer (CFO), Joe (Yifeng) Gao has the primary responsibility for planning, implementing, managing and controlling all financial-related activities for Frontage.
Read Full Story
News Frontage Sponsors the CABS workshop “Preclinical and Early Phase Development of Biologics and Small Molecules”
1.7.2019

Frontage Sponsors the CABS workshop “Preclinical and Early Phase Development of Biologics and Small Molecules”

CABS workshop "Preclinical and Early Phase Development of Biologics and Small Molecules" sponsored by Frontage Laboratories, Inc., was successfully held on December 11th, 2018 at DoubleTree Hotel in Burlingame, California. The workshop featured four presentations by leading experts in areas of preclinical and early stage development of biologics and small molecule therapeutics and a lively panel discussion on hot topics and emerging trends in biologics and small molecule drug development.
Read Full Story
7.11.2018

Frontage Receives 2018 CRO Leadership Awards

Exton, PA, July 10, 2018: Frontage Laboratories, Inc. has been named as a 2018 CRO Leadership Awards recipient by Life Science Leader magazine. The publication annually asks pharmaceutical and biopharmaceutical companies to rate the capability and performance of contract research organizations.
Read Full Story
News Dr. Song Li Awarded Entrepreneur Of The Year®
6.19.2018

Dr. Song Li Awarded Entrepreneur Of The Year®

Dr. Song Li, Founder and CEO of Frontage Laboratories, Inc., has been awarded the Entrepreneur Of The Year®Award for 2018. 
Read Full Story